Please login to the form below

pulmonary embolism

This page shows the latest pulmonary embolism news and features for those working in and with pharma, biotech and healthcare.

AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib

as pulmonary embolism (PE) or deep vein thrombosis (DVT) and an uncompetitive dose.

Latest news

FDA panel undermines Lilly and Incyte’s baricitinib hopes

baricitinib’s potential to cause side effects such as pulmonary embolism and venous thromboembolism.
AbbVie’s JAK inhibitor upadacitinib clears another phase III trial

There was a fatality from a stroke in the trial in a patient, plus one case of a pulmonary embolism, although AbbVie said these occurred in at-risk patients.
Xarelto beats aspirin for recurrent blood clots

Janssen's parent company Johnson &Johnson (J&J) said in a statement that up to 10% of people who have suffered a VTE (usually a deep vein thrombosis or pulmonary embolism)
NICE recommends Daiichi Sankyo's Lixiana for DVT and PE

NICE has backed Daiichi Sankyo's Lixiana (edoxaban) in final guidance as a treatment for adults with deep vein thrombosis and pulmonary embolism. ... NICE concluded that Lixiana was a cost-effective use of NHS resources for deep vein thrombosis (DVT) and
Daiichi’s new anticoagulant recommended by NICE

Specifically, in draft guidance NICE is minded to recommend Lixiana (edoxaban) as an option for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation with one or more ... NICE has already recommended Lixiana for the

More from news
Approximately 4 fully matching, plus 55 partially matching documents found.

Latest Intelligence

Modern anticoagulants threaten status quo

embolism in patients with AF and for the prevention of VTE in patients undergoing knee or hip replacement surgery. ... In one phase III trial, idrabiotaparinux sodium was non-inferior to warfarin in preventing the recurrent VTE at three months in

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Medical Writer: Salary is DOE

Account Manager: Negotiable

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Director or Senior Account Director: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Senior Writer, Healthcare Advertising, London: Excellent package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Systematic Review Lead- London: Negotiable

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Graduate Scientific Editor: DOE

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Account Manager – Healthcare Advertising: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Account Manager- 4 days per week or full-time: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Market Access Consultant - Greater Manchester: Negotiable

Senior Training Manager - Surrey: Competitive Salary &Bonus

Subscribe to our email news alerts

PMHub

Add my company

Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....